{"title":"Process Evaluation of Digital Mental Health Interventions for Psychosis: Scoping Review With Framework Synthesis.","authors":"Chloe Hampshire, Charlotte Dack, Shadi Daryan, Carolina Fialho, Rayan Taher, Ashley-Louise Teale, Jenny Yiend, Pamela Jacobsen","doi":"10.2196/88032","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Implementing digital mental health interventions (DMHI) for those with psychosis is a persistent challenge. A process evaluation, or studies conducted alongside trials, is one research method that may address this issue. However, a synthesis of process evaluation data in this area is missing.</p><p><strong>Objective: </strong>This study aimed to understand what is known about context, implementation, and mechanisms of impact by synthesizing process evaluation data from trials evaluating DMHIs used by people with psychosis.</p><p><strong>Methods: </strong>A scoping review using a 2-phase search strategy underpinned by the Medical Research Council (MRC) process evaluation framework was conducted. Database searches of Cochrane Central Register of Controlled Trials and PsycInfo in 2024 and 2025 first identified an index sample of peer-reviewed trials predominantly conducted in the United Kingdom (≥50% of samples from the United Kingdom in multicountry studies). Next, papers linked to the index sample were retrieved and included if they reported process evaluation data as operationalized in the MRC framework. Two authors independently screened references, extracted summary data, and assessed the quality of index trials. One author qualitatively synthesized process evaluation data using a deductive framework synthesis approach using the MRC framework. Findings were triangulated with senior authors and presented as a narrative synthesis.</p><p><strong>Results: </strong>Searches identified 14 DMHIs and 45 papers reporting process evaluation data, though only 2 were labeled as such. Qualitative syntheses of process evaluation data generated five themes aligned with the MRC framework: (1) enhancing fit and supporting delivery (implementation strategies); (2) DMHI implementation varied across users, staff, and delivery settings (implementation outcomes); (3) helping users to respond in more helpful ways (mechanisms); (4) addressing perceived and actual implementation factors (context); and (5) limited impact of user characteristics on DMHI outcomes (context).</p><p><strong>Conclusions: </strong>There is preliminary evidence that DMHIs can be delivered to people experiencing psychosis within trial settings, although use varied between individuals. Future implementation efforts may benefit from addressing contextual factors influencing DMHI use, including users' treatment needs and preferences, everyday demands, and staff availability for blended interventions. Future research could evaluate implementation strategies, validate how and for whom DMHIs work, and embed process evaluation in trials.</p><p><strong>Trial registration: </strong>PROSPERO CRD42024439117; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024439117.</p>","PeriodicalId":36351,"journal":{"name":"JMIR Human Factors","volume":"13 ","pages":"e88032"},"PeriodicalIF":3.9000,"publicationDate":"2026-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13448200/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Human Factors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/88032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Implementing digital mental health interventions (DMHI) for those with psychosis is a persistent challenge. A process evaluation, or studies conducted alongside trials, is one research method that may address this issue. However, a synthesis of process evaluation data in this area is missing.
Objective: This study aimed to understand what is known about context, implementation, and mechanisms of impact by synthesizing process evaluation data from trials evaluating DMHIs used by people with psychosis.
Methods: A scoping review using a 2-phase search strategy underpinned by the Medical Research Council (MRC) process evaluation framework was conducted. Database searches of Cochrane Central Register of Controlled Trials and PsycInfo in 2024 and 2025 first identified an index sample of peer-reviewed trials predominantly conducted in the United Kingdom (≥50% of samples from the United Kingdom in multicountry studies). Next, papers linked to the index sample were retrieved and included if they reported process evaluation data as operationalized in the MRC framework. Two authors independently screened references, extracted summary data, and assessed the quality of index trials. One author qualitatively synthesized process evaluation data using a deductive framework synthesis approach using the MRC framework. Findings were triangulated with senior authors and presented as a narrative synthesis.
Results: Searches identified 14 DMHIs and 45 papers reporting process evaluation data, though only 2 were labeled as such. Qualitative syntheses of process evaluation data generated five themes aligned with the MRC framework: (1) enhancing fit and supporting delivery (implementation strategies); (2) DMHI implementation varied across users, staff, and delivery settings (implementation outcomes); (3) helping users to respond in more helpful ways (mechanisms); (4) addressing perceived and actual implementation factors (context); and (5) limited impact of user characteristics on DMHI outcomes (context).
Conclusions: There is preliminary evidence that DMHIs can be delivered to people experiencing psychosis within trial settings, although use varied between individuals. Future implementation efforts may benefit from addressing contextual factors influencing DMHI use, including users' treatment needs and preferences, everyday demands, and staff availability for blended interventions. Future research could evaluate implementation strategies, validate how and for whom DMHIs work, and embed process evaluation in trials.
背景:对精神病患者实施数字心理健康干预(DMHI)是一个持续的挑战。过程评估,或与试验一起进行的研究,是一种可以解决这个问题的研究方法。然而,在这方面的工艺评价数据的综合是缺失的。目的:本研究旨在通过综合评估精神病患者使用DMHIs的试验的过程评估数据,了解其背景、实施和影响机制。方法:采用医学研究委员会(MRC)流程评估框架支持的两阶段检索策略进行范围综述。Cochrane Central Register of Controlled Trials和PsycInfo在2024年和2025年的数据库检索首次确定了一个主要在英国进行的同行评议试验的索引样本(在多国研究中来自英国的样本≥50%)。接下来,检索与索引样本相关的论文,如果它们报告了在MRC框架中可操作的过程评估数据,则将其包括在内。两位作者独立筛选参考文献,提取汇总数据,并评估索引试验的质量。一位作者使用MRC框架的演绎框架综合方法定性地综合了过程评估数据。研究结果与资深作者进行了三角测量,并以叙事综合的形式呈现。结果:检索到14篇DMHIs和45篇报告过程评估数据的论文,尽管只有2篇被标记为这样。过程评估数据的定性综合产生了与MRC框架一致的五个主题:(1)加强契合和支持交付(实施战略);(2) DMHI的实施因用户、员工和交付设置而异(实施结果);(3)帮助用户以更有益的方式(机制)回应;(4)处理感知和实际的实施因素(语境);(5)用户特征对DMHI结果的影响有限(背景)。结论:有初步证据表明,DMHIs可以在试验环境中提供给患有精神病的人,尽管使用情况因人而异。未来的实施工作可能受益于解决影响DMHI使用的环境因素,包括用户的治疗需求和偏好、日常需求以及工作人员对混合干预措施的可用性。未来的研究可以评估实施策略,验证DMHIs如何工作以及为谁工作,并在试验中嵌入过程评估。试验注册:PROSPERO CRD42024439117;https://www.crd.york.ac.uk/PROSPERO/view/CRD42024439117。